Schedule 13G/A

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, A68EmlHWB3dlKpbMCWLtRQpZ2b/LU1j3Qna8lDsdMyj3krHi52wLrZPHrl06TQQ6 MNMqr3losPTSBwkarHMvXQ== 0001193125-05-028544.txt : 20050214 0001193125-05-028544.hdr.sgml : 20050214 20050214123752 ACCESSION NUMBER: 0001193125-05-028544 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20050214 DATE AS OF CHANGE: 20050214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NOVAMED INC CENTRAL INDEX KEY: 0001086939 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT SERVICES [8741] IRS NUMBER: 364116193 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-58295 FILM NUMBER: 05605950 BUSINESS ADDRESS: STREET 1: 980 N MICHIGAN AVENUE STREET 2: SUITE 1620 CITY: CHICAGO STATE: IL ZIP: 60611 BUSINESS PHONE: 3126644100 MAIL ADDRESS: STREET 1: 980 N MICHIGAN AVENUE STREET 2: SUITE 1620 CITY: CHICAGO STATE: IL ZIP: 60611 FORMER COMPANY: FORMER CONFORMED NAME: NOVAMED EYECARE INC DATE OF NAME CHANGE: 19990521 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: WINJUM STEPHEN J CENTRAL INDEX KEY: 0001106477 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: BUSINESS PHONE: 3126644100 MAIL ADDRESS: STREET 1: 980 NORTH MICHIGAN AVENUE STREET 2: SUITE 1620 CITY: CHICAGO STATE: IL ZIP: 60611 SC 13G/A 1 dsc13ga.htm SCHEDULE 13G/A Schedule 13G/A

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 29549

SCHEDULE 13G

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED

PURSUANT TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS

THERETO FILED PURSUANT TO 13d-2(b)

(Amendment No. 4)*

NOVAMED, INC.

(Name of Issuer)

COMMON STOCK, par value $.01 per share

(Title of Class of Securities)

66986W 10 8

(CUSIP Number)

December 31, 2004

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)

¨ Rule 13d-1(c)

x Rule 13d-1(d)

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

SCHEDULE 13G


CUSIP No. 66986W 10 8		Page 2 of 5 Pages


1.		*NAME OF REPORTING PERSONS* *I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)* *STEPHEN J. WINJUM*
2.		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ¨ (b) ¨
3.		*SEC USE ONLY*
4.		*CITIZENSHIP OR PLACE OF ORGANIZATION* *U.S.A.*

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

5. SOLE VOTING POWER

2,684,975

6. SHARED VOTING POWER

-0-

7. SOLE DISPOSITIVE POWER

2,684,975

8. SHARED DISPOSITIVE POWER

-0-


9.	*AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON* *2,684,975*
*10.*	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*	¨
*11.*	*PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)* *11.5%*
*12.*	TYPE OF REPORTING PERSON* IN

*SEE INSTRUCTIONS BEFORE FILLING OUT!


CUSIP No. 66986W 10 8		Page 3 of 5 Pages

Item 1

(a)

Name of Issuer:

NovaMed, Inc.

Item 1

(b)

Address of Issuer’s Principal Executive Offices:

980 North Michigan Avenue

Suite 1620

Chicago, Illinois 60611

Item 2

(a)

Name of Person Filing:

Stephen J. Winjum

Item 2

(b)

Address of Principal Business Office or, if None, Residence:

Stephen J. Winjum

NovaMed, Inc.

980 N. Michigan Avenue

Suite 1620

Chicago, Illinois 60611

Item 2

(c)

Citizenship:

U.S.A.

Item 2

(d)

Title of Class of Securities:

Common Stock, par value $.01 per share

Item 2

(e)

CUSIP Number:

66986W 10 8

Item 3.

If this Statement is Filed Pursuant to Rule 13d-1(b) or 13d-2(b) or (c), Check Whether the Person Filing is a:

Not Applicable.


CUSIP No. 66986W 10 8		Page 4 of 5 Pages



*Item 4.*	*Ownership:*

	*(a)*	*Amount Beneficially Owned:*

		2,684,975 ⁽¹⁾

	*(b)*	*Percent of Class:*

		11.5% ⁽¹⁾

	*(c)*	*Number of shares as to which person has:*

		(i)	sole power to vote or to direct the vote:

			2,684,975 ⁽¹⁾

		(ii)	shared power to vote or to direct the vote:

			-0-

		(iii)	sole power to dispose or to direct the disposition of:

			2,684,975 ⁽¹⁾

		(iv)	shared power to dispose or to direct the disposition of:

			-0-

⁽¹⁾ Includes 1,806,875 shares of common stock issuable upon exercise of options that are exercisable within 60 days of December 31, 2004.

*Item 5.*	*Ownership of Five Percent or less of a Class:*

	Not Applicable.

*Item 6.*	*Ownership of More than Five Percent on Behalf of Another Person:*

	Not Applicable.

*Item 7.*	*Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:*

	Not Applicable.

*Item 8.*	*Identification and Classification of Members of the Group:*

	Not Applicable.

*Item 9.*	*Notice of Dissolution of Group:*

	Not Applicable.

*Item 10.*	*Certification:*

	Not Applicable.


CUSIP No. 66986W 10 8		Page 5 of 5 Pages

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.


Date: February 11, 2005
		/S/ STEPHEN J. WINJUM
		Stephen J. Winjum

-----END PRIVACY-ENHANCED MESSAGE-----